{
  "pmcid": "7271663",
  "sha256": "eaba144a54e3034d428df555e0c05e457772902e5b9d8419258e710accfa439a",
  "timestamp_utc": "2025-11-09T16:12:53.738109+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.121052631578948,
    "reading_ease": 24.33315789473687,
    "word_count": 249
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "In a double-blind RCT"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In a double-blind RCT, adults at increased risk of acute kidney injury undergoing cardiac surgery in a single UK tertiary centre were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "adults at increased risk of acute kidney injury undergoing cardiac surgery in a single UK tertiary centre"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive sildenafil citrate 12.5 mg kg −1 i.v. over 150 min or dextrose 5%"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study assessed whether i.v. sildenafil citrate prevented acute kidney injury in at-risk patients undergoing cardiac surgery with cardiopulmonary bypass."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was serum creatinine measured at six post-randomisation time points."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 2,
        "evidence": "In a double-blind RCT"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "There were 60 subjects in the sildenafil group and 69 in the placebo control group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "The analysis population comprised eligible randomised patients that underwent valve surgery or combined coronary artery bypass graft and valve surgery"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The difference between groups in creatinine concentration was not statistically significant (MD: 0.88 μmol L −1 [–5.82, 7.59])."
      },
      "Harms": {
        "score": 1,
        "evidence": "There was a statistically significant increase in multiple organ dysfunction scores in the sildenafil group (MD: 0.54 [0.02, 1.07]; P =0.044)."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Clinical trial registration: ISRCTN18386427."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}